Sudden announcement! 6 companies make important results announcements in the evening! A company lost 39.6 billion yuan!
1, Yahuilong: 2023 annual results express announcement.
The company announced that during the reporting period, the company achieved operating income of 204,260890,000 yuan, a year-on-year decrease of 193,814790,000 yuan, a decrease of 4869%。Net profit attributable to shareholders of listed companies was 35,841420,000 yuan, a decrease of 6460%。
2. Maipu Medical: Announcement on the repurchase plan of the company's shares.
The company announced that the company intends to repurchase shares with 10 million yuan to 20 million yuan for employee stock ownership plans or equity incentives, and the maximum number of shares repurchased is 49 yuan.
3. Sanyou Medical: Announcement on the shareholding increase plan of one of the actual controllers of the company
The company announced that Mr. D**id Fan (Fan Xianglong), one of the actual controllers of the company and director, senior vice president and secretary of the board of directors, intends to use his own funds or self-raised funds to increase his holdings of the company's shares through centralized bidding through the Shanghai ** Exchange system from February 26, 2024 to April 30, 2024, with an increase of not less than RMB 40000000000 and not more than 600000,000 yuan.
4. Shenzhou Cell: 2023 Annual Results Express Announcement
The company announced that during the reporting period, the company achieved a total operating income of 188,734930,000 yuan, a year-on-year increase of 8446%；Realized a net loss attributable to owners of the parent company of 39,601830,000 yuan, a year-on-year decrease of 2370%；Net loss attributable to owners of the parent company before non-recurring gains and losses was 6,368050,000 yuan, a year-on-year decrease of 8391%。
5. Red Dragonfly: Announcement on the plan to repurchase the company's shares by centralized bidding transaction.
The company announced that the total amount of repurchase funds shall not be less than RMB 50 million (inclusive) and not more than RMB 100 million (inclusive), and the specific total amount of repurchase funds shall be subject to the total amount of funds actually used. The repurchased shares** shall not exceed RMB 7 (inclusive).
6. Chengda Bio: 2023 Annual Results Express Announcement.
The company announced that during the reporting period, the company achieved operating income of 175,010310,000 yuan, down 358%；Net profit attributable to owners of the parent company was 46,845100,000 yuan, a year-on-year decrease of 3439%；Net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 41,006660,000 yuan, a year-on-year decrease of 3836%。